Home › Funds › Private Harbour Investment Management & Counsel, LLC › VRTX

Private Harbour Investment Management & Counsel, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Private Harbour Investment Management & Counsel, LLC reported holding 4,295 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 2.38% of its reported portfolio and ranking #11 among its reported holdings. Private Harbour Investment Management & Counsel, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.29K sh
Reported value held$2.25M
Portfolio Weight2.38%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Private Harbour Investment Management & Counsel, LLC's VRTX position evolved

Private Harbour Investment Management & Counsel, LLC first disclosed a stake in VRTX in Q3 2023 at 5,551 shares (US$1.9M). The position peaked in Q2 2024 at 5,333 shares, worth US$2.5M. Across 13 filings, Private Harbour Investment Management & Counsel, LLC increased the stake 0 time(s), trimmed it 9 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 4,295 shares valued at US$2.2M — a reduction of -100 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.55K $1.93M New
Q4 2023 5.43K $2.21M Reduce
Q1 2024 5.40K $2.26M Reduce
Q2 2024 5.33K $2.50M Reduce
Q3 2024 5.31K $2.47M Hold
Q4 2024 5.09K $2.05M Reduce
Q1 2025 4.83K $2.34M Reduce
Q2 2025 4.78K $2.13M Reduce
Q3 2025 4.45K $1.74M Reduce
Q4 2025 4.44K $2.01M Hold
Q1 2026 4.38K $1.96M Reduce
Q2 2026 4.39K $2.18M Hold
Q3 2026 4.29K $2.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Private Harbour Investment Management & Counsel, LLC held VRTX?

Private Harbour Investment Management & Counsel, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Private Harbour Investment Management & Counsel, LLC's current position in VRTX?

As of Q3 2026, Private Harbour Investment Management & Counsel, LLC holds 4.29K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $2.25M, representing 2.38% of its reported portfolio and ranking #11.

Has Private Harbour Investment Management & Counsel, LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Private Harbour Investment Management & Counsel, LLC reduced its position in VRTX. The position peaked in Q2 2024 at 5.33K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.